GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,340 | -5,990 | N/A | N/A | -1,540 |
| Depreciation Amortization | 450 | 1,380 | N/A | N/A | 370 |
| Other Operating Activity | 810 | 340 | 0 | 0 | 630 |
| Operating Cash Flow | $-80 | $-4,270 | $N/A | $N/A | $-540 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -120 | -400 | 0 | 0 | -60 |
| Investing Cash Flow | $-120 | $-400 | $N/A | $N/A | $-60 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 60 | 4,380 | 0 | 0 | 750 |
| Financing Cash Flow | $60 | $4,380 | $N/A | $N/A | $750 |
| Exchange Rate Effect | 0 | -3 | N/A | N/A | N/A |
| Beginning Cash Position | 420 | 720 | N/A | N/A | 720 |
| End Cash Position | 270 | 420 | N/A | N/A | 870 |
| Net Cash Flow | $-150 | $-300 | $N/A | $N/A | $140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80 | -4,270 | N/A | N/A | -540 |
| Free Cash Flow | -80 | -4,270 | 0 | 0 | -540 |